Amprion's αSynuclein Seed Amplification Assay to be Sh

/PRNewswire/ -- Amprion, a global leader in the advancement of neurodegenerative disorder diagnosis, will be in attendance at the Alzheimer's Association...

Related Keywords

Texas , United States , Luis Concha , Russell Lebovitz , Douglas Galasko , Francesca Capotosti , Doug Galasko , Lawren Vandevrede , Prnewswire Amprion , Oskar Hansson , Claudio Soto , Ethan Metelenis , Amprion Syntap Biomarker , Christina Renfroe , Amprion Syntap , University Of California San Diego , Alzheimer Association International Conference , Linkedin , University Of California San Francisco , Laboratory Developed Test , Weill Institute For Neurosciences , A Featured Research Session , Drug Administration , University Of Texas Health Sciences Center Houston , Association International , Lewy Body Dementia , Lewy Body , Exhibit Hall , California San , Amprion Associate Director , Featured Research Session , Cerebrospinal Fluid Alpha Synuclein Assay , Disease Neurodegenerative Syndromes , Aging Center , Weill Institute , Lewy Bodies , Biomarker Test , Breakthrough Device Designation , Texas Health Sciences Center , Amprion , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology ,